Last verified: 6 May 2026
On 6 February 2025, the Securities and Exchange Board of India confirmed a personal penalty of Rs 30 lakh on a former non-executive independent director who had served on the audit committee of a then-listed Hyderabad advertising-technology firm. Three weeks earlier, the Securities Appellate Tribunal had refused to stay the underlying order. Two short paragraphs in a regulator’s PDF, and a director’s retirement income shrank by Rs 30 lakh in one afternoon. No criminal trial. No oral hearing on the morning of the order. Just a final adjudication, a quantified penalty, and a recovery notice.
What the audit committee should have caught is itself the tragedy. Accounting irregularities ran across six financial years, from FY14-15 to FY19-20. The combined penalty across the company and its officers crossed Rs 35 crore. The market capitalisation collapsed. The order was a public-record reminder that the rules on independent director liability and D&O insurance in India had quietly shifted while many directors were still operating under 2018-era assumptions. Passive attendance, the assumption went, would always be a defence. Not anymore.
Zoom out, and the pattern is even starker. In April 2024, the SEBI order in the matter of Manpasand Beverages Limited held audit committee members of a Vadodara-listed beverages company to a higher standard for relying on management explanations rather than independently scrutinising the financial statements. In June 2024, the SEBI adjudication order in the matter of Maxheights Infrastructure Limited imposed a Rs 9 lakh penalty for what SEBI called a misclassification of a part-time-employed person as “independent”. May 2025 brought the SEBI informal guidance to InfoBeans Technologies Limited and a tightening of the pre-IPO board test. SEBI’s August 2021 LODR amendment, effective January 2022, had already extended the D&O insurance mandate from the top 500 to the top 1,000 listed companies. Broker reports indicate substantial year-on-year hikes in D&O premiums. The post-IL&FS pattern of mass independent director resignations, which surfaced in 2018-2020 and earned the label “great resignation”, has not really subsided.
If you sit on a board today, or are being approached for one, this story is your future risk profile in microcosm. The four-limb test of Section 149(12) of the Companies Act, 2013 looks like a safe harbour on paper. In practice, the harbour has rocks. D&O (Directors and Officers) insurance is the financial backstop. But Indian D&O policies have exclusions, sub-limits, and Side-by-side architecture that most directors never fully read until they are filing a claim. This page delivers the law (across nine statutes), the seven 2024-2025 SEBI orders, the D&O policy mechanics, and a 15-question board-acceptance checklist drawn from how senior practitioners actually evaluate offers today.
Before the case-walk, the policy mechanics, and the checklist, a clean working answer to the core question every prospective independent director asks.
In India, an independent director liability and D&O insurance in India position works like this: an independent director is personally liable under Section 149(12) of the Companies Act, 2013 only for acts done with their knowledge through board processes, with their consent or connivance, or where they failed to act diligently. D&O (Directors and Officers) liability insurance, mandatory for top 1,000 SEBI-listed companies under Regulation 25(10) of the SEBI LODR Regulations, 2015, provides the financial backstop covering legal defence, settlements, and regulatory penalties, with fraud and wilful misconduct exclusions.
That working definition is the floor. The ceiling is what each of the four limbs actually requires, how SEBI now reads “due diligence”, which exclusions trap incoming directors, and what 2026 INR premium ranges look like for a serious cover.
What is independent director liability under Indian law?
Independent director liability is the legal exposure faced by a director who, by definition, is meant to be independent of the management and promoter group. The role exists to add an outside check on dominant shareholders. The liability framework exists because the role can be misused, and because shareholders, regulators, and creditors need a way to hold the check accountable when the check fails.
The starting point is Section 149 of the Companies Act, 2013. Section 149(6) sets out the eligibility criteria, including the absence of pecuniary relationships with the company, its promoters, and its group. Section 149(12) carves the liability framework. An independent director is liable for acts of omission or commission by the company that occurred with their knowledge through board processes, with their consent or connivance, or where they had not acted diligently. Anything outside these four limbs is, in theory, outside their personal exposure.
That is the theory. Application has been a different story. Readers regularly conflate “independent” with “immune” because the statute reads like a shield. It is not a shield. It is a conditional defence, and each condition is contestable on the facts. For a deeper treatment of how the role itself is constituted, including appointment procedures, eligibility maintenance, and removal grounds, see the complete legal framework for independent directors under the Companies Act 2013.
Now, here’s where it gets interesting. The role of the independent director was reshaped by 2009. The Satyam fraud exposed the inadequacy of pre-2013 governance norms. The Companies Act, 2013 enacted the Section 149 framework. The SEBI LODR Regulations, 2015 added Regulation 25 oversight. The IL&FS crisis of 2018 triggered the first SEBI mandate (October 2018, by amendment to LODR) requiring D&O cover for the top 500 listed companies. MCA General Circular No. 05/2020 (2 March 2020) clarified that prosecutions against independent directors require concrete evidence of personal complicity. The August 2021 LODR amendment, effective January 2022, expanded the D&O mandate to the top 1,000 and tightened resignation disclosures.
The concept of “independent” director under Section 149(6)
Section 149(6) lists about a dozen criteria. The director must not be a promoter or related to one. They must not have had a pecuniary relationship with the company in the two preceding financial years. They must not be a partner or executive at the company’s auditor or legal advisor. They must register on the Independent Directors’ Databank maintained by the Indian Institute of Corporate Affairs (IICA), unless exempted on the proficiency-test ground.
A practical confusion: many readers treat non-executive directors and independent directors as interchangeable. They are not. A non-executive director is simply a director not involved in day-to-day management. Many non-executive directors are promoter-nominees or hold pecuniary relationships with the company. Independence is a tighter category. For a side-by-side breakdown, see the difference between executive, non-executive, and independent directors.
Liability vs accountability: the distinction India still gets wrong
Here’s the thing. Liability is a legal consequence; accountability is a normative expectation. The two move on different timelines.
An independent director can be perfectly accountable to shareholders, brief the audit committee diligently, raise red flags in writing, and still face statutory liability if the four-limb test trips them up. The reverse is also true. A director can sleep through every meeting and dodge formal liability if the company’s compliance officer never put the right paper in front of them.
Senior counsel reading this material will tell you the liability test asks “what did the board record show”, while accountability asks “what should the director have done”. When SEBI investigates, it works backwards from the record. So the practical lesson, in our view, is that paper trails matter more than self-perception. If you raised a concern, get it minuted. If you abstained, get the abstention minuted. If you signed under pressure, write a separate dissent letter contemporaneously and have it placed on the company’s records. The minute book is your defence.
The post-Satyam framework: how 2009 reshaped statutory liability
The 2009 Satyam Computer Services fraud exposed roughly USD 1.5 billion in fictitious cash. It also exposed the weakness of the Companies Act, 1956 framework, which lacked specific independent-director liability provisions. The 2013 Act folded the four-limb test into Section 149(12) precisely to set boundaries on what an independent director could and could not be held to. The 2018 IL&FS implosion then forced the next iteration: D&O insurance, which had been a quiet corporate add-on, became a regulatory expectation. By 2021, SEBI had pushed the D&O mandate from top 500 to top 1,000 listed companies. The shadow of the 1956 Act still informs how some long-serving directors approach the role. That mindset is the single most common source of avoidable liability.
A common community question raised on LinkedIn legal threads: “Are independent directors really watchdogs, or just paper tigers?” The honest answer is that the watchdog framing was always aspirational. The 2013 Act tried to give the role teeth. Whether it succeeded is the running question of the next eighteen sections.
So who is exposed, and how exactly? That is the four-limb test, and it lives in Section 149(12) of the Companies Act, 2013.
The Section 149(12) safe harbour: the four-limb test in practice
Section 149(12) of the Companies Act, 2013 is the headline defence for independent and non-executive directors. It says an independent director is liable for company acts only if four conditions are read together. The acts occurred with the director’s knowledge, attributable through board processes; the acts had the director’s consent or connivance; or the director failed to act diligently. The phrasing is deliberately compact. The interpretation is anything but.
A reader could treat the section as a clean safe harbour. The reality, after the SEBI final order in the matter of Brightcom Group Ltd. (6 February 2025) and the SEBI Manpasand Beverages adjudication of April 2024, is that audit committee members face an elevated standard, and the “due diligence” limb has expanded to cover what a reasonable independent director ought to have asked, not just what the company chose to share. The section still functions as a defence. It is no longer a doorway out.
The four limbs decoded: knowledge, board process attribution, consent or connivance, due diligence
The four limbs are best read as questions a regulator will pose at the time of an investigation. Did the matter come up at a board or committee meeting that the director attended? Was the matter circulated as part of the agenda papers? Did the director vote in favour, abstain, or dissent? Did the director ask the kinds of questions a diligent director would ask, given the materials available?
The first limb (knowledge through board processes) is usually the easiest to satisfy from a regulator’s side, because attendance records, minutes, and circulated papers are documentary. The second limb (consent or connivance) requires evidence of active participation in the wrongful act. The third limb (failed to act diligently) is where most regulator energy goes. It is the open texture of the test.
| Limb | What it requires | Common failure pattern | Director’s defence |
|---|---|---|---|
| 1. Knowledge through board processes | The act came up at a board or committee meeting; agenda papers circulated | Attending without reviewing the pre-read; signing minutes without review | Documented questions raised in advance of the meeting; minuted clarifications |
| 2. Consent or connivance | Active vote in favour or behind-the-scenes agreement | Voting “yes” on a resolution without scrutiny | Documented dissent letter; abstention recorded in minutes |
| 3. Failure to act diligently | Did not ask the questions a reasonable director would | Relying solely on management explanations | Documented independent verification, third-party reports, follow-up questions |
| 4. Failure to ensure compliance with statute | Did not insist on a compliance review where required | Treating compliance officer’s clean report as conclusive | Periodic compliance audit committee reviews, documented escalation when issues surface |
So what happens if a director dissents on a resolution but it still passes? The dissent is a strong defence under the second limb, provided it is recorded in the minutes. Most companies will record only the result of the vote unless the dissenter insists.
The smarter strategy is to dictate a one-paragraph dissent that the company secretary types into the minutes verbatim, then send a follow-up email confirming the dissent within twenty-four hours. The email creates a contemporaneous record that survives later minute revisions.
How courts and tribunals actually apply Section 149(12)
The Supreme Court ruling in Chintalapati Srinivasa Raju v. Securities and Exchange Board of India, (2018) 7 SCC 443 is the foundational precedent on the “significant role” threshold for SEBI enforcement against independent directors. The court held that independent directors cannot be made accountable for SEBI violations unless they played a significant decision-making role. That formulation has been carried into successive SEBI and SAT proceedings. A similar protection runs through Sunita Palita v. M/s. Panchami Stone Quarry, (2022) 10 SCC 152, which reaffirmed that independent and non-executive directors are not criminally liable under Section 141 of the Negotiable Instruments Act, 1881 absent specific allegations of conducting business at the relevant time.
In practice, regulators distinguish between three director archetypes. The promoter-nominee non-executive director is treated as effectively an executive proxy. The professional non-executive director with no audit committee role is closer to the Section 149(12) safe harbour. The independent director who chairs or sits on the audit committee is the most exposed. SEBI’s reasoning is straightforward. If you are on the audit committee, you signed off on the financial statements. If the financials were misstated, the committee was either complicit or negligent.
But practitioners are seeing pushback at the appellate stage. The Securities Appellate Tribunal, while it confirmed the Brightcom outcome, has generally pressed SEBI for evidence of the specific role each director played. The “bald averment” defence from National Small Industries Corp. Ltd. v. Harmeet Singh Paintal, (2010) 3 SCC 330 still has bite where the regulator cannot point to specific conduct. The trend is unambiguous, though. The threshold for an independent director to escape liability has risen, particularly where the audit committee membership intersects with financial misstatement allegations.
Where the safe harbour breaks: audit committee membership and the elevated standard
Audit committee membership is the single most common pressure point for the safe harbour. The committee has statutory duties under Section 177 of the Companies Act, 2013 and under SEBI LODR Regulation 18. It must review financial statements, related-party transactions, internal audit reports, and whistleblower complaints. The committee’s report is part of the directors’ report. If the financials were misstated, the committee chair and members are presumed to have read them.
The Brightcom matter illustrated this with painful clarity. The independent director who held a Rs 30 lakh personal penalty had served on the audit committee. The Manpasand outcome went further. SEBI held that committee members who relied on the managing director’s explanations rather than independently scrutinising the figures had themselves shown that the committee was functioning under management influence. The very act of passive reliance was treated as evidence that the committee was not independent. That is a doctrinal expansion of the third limb (due diligence) into territory many directors did not anticipate.
Is the IICA proficiency test enough to protect a director from this elevated standard? Honestly, no. The proficiency test certifies awareness of the statutory framework. It does not certify the depth of scrutiny a member brings to financial statements. What it does is signal to the company that the director understands the framework. The protection is built on what the director then does with that understanding inside the audit committee room.
Section 149(12) liability vs Section 166 fiduciary duty breach
Section 166 of the Companies Act, 2013 imposes a positive fiduciary duty on every director, including independent directors. The director must act in good faith, exercise reasonable care, skill, and diligence, and avoid conflicts of interest. Section 149(12) protects against vicarious liability for the company’s wrongdoing. Section 166 is a personal duty of conduct.
The two interact in regulator analysis. SEBI may close out a Section 149(12) inquiry on the four-limb test. It may then open a separate inquiry under Section 166 if the director’s personal conduct (related-party dealings, acceptance of disqualifying gifts, failure to disclose a conflict) is itself the issue. Section 149(12) is a shield against company misconduct. Section 166 is a sword against the director’s personal misconduct. Both can run at the same time. For the day-to-day duty matrix, see the day-to-day responsibilities of an independent director.
The practical reality is that most plaintiffs and regulators plead both heads in the alternative. The director must be ready to defend both fronts. A clean Section 149(12) defence (minuted dissents, documented questions) is also strong evidence under Section 166, because the same paper trail shows the director discharging their duty of care.
So which statutes actually expose the director? That map runs across nine instruments.
Civil and statutory liability of independent directors: the 9-statute map
The Section 149(12) defence sits inside the Companies Act. The director’s liability surface, unfortunately, runs much wider. Independent directors face civil and statutory exposure across at least nine statutes, each with its own trigger event, pleading standard, and personal-exposure logic. D&O policies typically cover the legal defence costs across most of these, with carve-outs for fraud, criminal conduct, and certain regulatory penalties.
This is the territory most independent directors learn under pressure, often after receiving an SCN from a regulator they had not realised had jurisdiction over them. A consolidated view of the exposure surface is the prerequisite for any conversation with the broker about D&O sub-limits.
Companies Act 2013: Sections 149(12), 166, 197(13), 447
The Companies Act remains the spine. Section 149(12) of the Companies Act, 2013 sets the four-limb test. Section 166 imposes the fiduciary duty. Section 197(13) addresses insurance taken by the company on behalf of its key managerial personnel and excludes the premium from being treated as remuneration unless the personnel is proved guilty. Section 447 of the Companies Act, 2013 criminalises fraud, with imprisonment of six months to ten years and fines up to three times the amount involved. Section 447 is the heaviest stick, and it carves through any safe harbour because fraud is, by definition, a Section 149(12) limb-two issue (consent or connivance).
SEBI LODR Regulations 2015: Regulations 17, 18, 25(10) and the 2021 amendment
The SEBI Listing Obligations and Disclosure Requirements Regulations, 2015 add a layer of listed-company obligations. Regulation 17 governs board composition. Regulation 18 sets the audit committee charter. Regulation 25 regulates independent director appointments, removals, and resignations. Regulation 25(10) was first inserted in October 2018, requiring the top 500 listed companies to take out D&O insurance for independent directors. The August 2021 amendment, effective January 2022, expanded the mandate to the top 1,000 listed companies. The 2021 amendment also imposed a 7-day disclosure obligation for resignation reasons and a 1-year cooling-off before joining a non-independent role at the same listed entity.
The LODR’s positive duty framing matters. Listed-company independent directors are not merely passive shields against liability. They are required to discharge specific governance functions and to disclose specific events, with statutory penalties for non-disclosure.
The Insolvency and Bankruptcy Code, 2016: Sections 66, 67, 69 and the PUFE framework
The Insolvency and Bankruptcy Code, 2016 introduces a different liability vector altogether. The PUFE framework (Preferential, Undervalued, Fraudulent, Extortionate transactions) under Section 66 and adjacent sections allows a Resolution Professional to claw back transactions the company entered into in the run-up to insolvency. Sections 67 and 69 add specific personal liability vectors for directors who allowed the company to trade fraudulently or to default on creditors. We treat IBC personal exposure in detail in the section on the IBC and personal exposure below.
NFRA Rules 2018, FEMA, PMLA, NI Act, IT Act, GST, environmental statutes
The long-tail statutes are where most independent directors are caught off-guard. Section 138 of the Negotiable Instruments Act, 1881 criminalises cheque dishonour, and Section 141 extends the offence to directors in charge of business at the relevant time. The case law here is extensive. Aneeta Hada v. M/s Godfather Travels & Tours Pvt. Ltd., (2012) 5 SCC 661 held that the company must be impleaded as an accused for vicarious liability under Section 141 to attach to directors. The Paintal ruling held that bald averments are insufficient; the prosecution must plead the specific role of the director. The combined effect is a procedural shield that defeats most boilerplate cheque-bounce complaints, but only if the director’s counsel raises the points correctly and early.
The Foreign Exchange Management Act, 1999 holds directors personally liable for FEMA contraventions where they were “in charge of and responsible for” the conduct of the business. The Prevention of Money Laundering Act, 2002 has similar personal-liability hooks. The Information Technology Act, 2000 attaches personal liability for officer-attributed offences. The Goods and Services Tax laws contain director-recovery provisions where the company defaults on undisputed tax dues.
The newest entrant is the Digital Personal Data Protection Act, 2023. Section 17 of the Digital Personal Data Protection Act, 2023 holds officers personally liable where data breaches occur with their consent, connivance, or attributable to neglect. The maximum entity penalty under the Act is Rs 250 crore. Personal liability scales with the entity’s culpability and the officer’s connection to the breach. We return to DPDP in the future risk section.
| Statute | Section | Trigger | Personal exposure for ID | D&O coverage typically |
|---|---|---|---|---|
| Companies Act, 2013 | 149(12), 166, 447 | Fraud, breach of fiduciary duty | High; Section 447 includes imprisonment | Defence costs covered; penalties partially covered (Side A) |
| SEBI LODR, 2015 | 17, 18, 25(10) | Disclosure failures, board composition non-compliance | Moderate; mostly monetary | Defence + most penalties (subject to regulatory exclusion) |
| IBC, 2016 | 43, 45, 50, 66 | Pre-insolvency transactions, fraudulent trading | High; clawback + personal payment orders | Defence covered; clawback amounts excluded |
| NI Act, 1881 | 138, 141 | Cheque dishonour by company | Moderate; criminal complaint | Defence covered; settlements typically covered |
| FEMA, 1999 | 42 | Foreign exchange contravention | Moderate; up to 3x amount involved | Defence covered; civil penalties covered |
| PMLA, 2002 | 70 | Money laundering by company | High; criminal proceedings | Defence covered; final-conviction penalties excluded |
| IT Act, 2000 | 85 | Officer-attributed cyber offences | Moderate | Defence covered |
| GST Act, 2017 | 89 | Tax recovery from director | Moderate; civil recovery | Generally not covered (commercial exclusion) |
| DPDP Act, 2023 | 17 | Data breach with neglect/connivance | Moderate to high | Emerging coverage; sub-limits common |
Even this nine-statute map is not exhaustive. Sector-specific regulators (RBI for banking, IRDAI for insurance companies, IBBI for insolvency practitioners) carry their own personal-liability provisions. The pattern is consistent. A director who joins a regulated-sector listed company should assume that at least three statutes (Companies Act, SEBI LODR, sector statute) carry personal liability, and that D&O cover should be benchmarked against the combined exposure, not against any single instrument.
Independent director liability: the 9-statute exposure map
| Statute | Trigger | Personal exposure | D&O coverage |
|---|---|---|---|
| Companies Act, 2013Sections 149(12), 166, 197, 447 | Knowledge / consent / connivance / lack of due diligence; fiduciary duty breach; managerial remuneration; fraud. | Penalty + imprisonment + disqualification. | Yes (subject to fraud carve-out for s.447). |
| SEBI LODR, 2015Regulations 17, 18, 25(10) | Board composition, audit committee functioning, D&O insurance mandate (top 1,000 listed). | Monetary penalty (often Rs 5 lakh – Rs 30+ lakh per ID). | Yes (regulator penalties typically covered, with carve-outs). |
| IBC, 2016Sections 43, 45, 50, 66, 67, 69 | Preferential / undervalued / fraudulent / extortionate transactions; wrongful trading. | Personal contribution order from NCLT. | Yes (Side A critical when company is in CIRP). |
| NFRA Rules, 2018Rules 11, 13 | Audit committee oversight failures on financial reporting. | Penalty + debarment from auditor / committee positions. | Partial – final-adjudication clause matters. |
| FEMA, 1999Section 42 (officer liability) | Foreign exchange contraventions – neglect / consent / connivance. | Penalty (typically multiple of contravention amount). | Yes (specific FEMA rider often required). |
| PMLA, 2002Section 70 | Money-laundering offences attributable to director. | Imprisonment + attachment of assets. | Limited – wilful misconduct exclusion typically triggers. |
| NI Act, 1881Sections 138, 141 | Cheque dishonour where director was “in charge of and responsible for” business. | Imprisonment up to 2 years + fine. | Yes (defence costs); subject to specific-role pleading defence. |
| IT Act + DPDP, 2023IT Act s.85; DPDP s.17 | Data breaches, cyber offences with consent / connivance / neglect. | Penalty up to Rs 250 crore on entity (DPDP); personal officer liability. | Yes – DPDP rider increasingly standard from 2025. |
| GST + environmental statutesCGST s.137; Water/Air Acts officer-in-charge clauses | Tax evasion / pollution offences attributable to officer. | Imprisonment + fine. | Limited – many policies exclude environmental and tax-evasion (vs civil tax dispute). |
Companies Act, 2013
Sections149(12), 166, 197, 447TriggerKnowledge / consent / connivance / due-diligence breach; fiduciary duty breach; remuneration; fraud.Personal exposurePenalty + imprisonment + disqualification.D&OYes (s.447 fraud carve-out applies).SEBI LODR, 2015
SectionsRegulations 17, 18, 25(10)TriggerBoard composition, audit committee, D&O mandate (top 1,000 listed).Personal exposureMonetary penalty (often Rs 5 lakh – Rs 30+ lakh per ID).D&OYes (carve-outs apply).IBC, 2016
Sections43, 45, 50, 66, 67, 69TriggerPreferential / undervalued / fraudulent / extortionate transactions; wrongful trading.Personal exposurePersonal contribution order from NCLT.D&OYes – Side A critical when company is in CIRP.NFRA Rules, 2018
SectionsRules 11, 13TriggerAudit committee oversight failures on financial reporting.Personal exposurePenalty + debarment from auditor / committee positions.D&OPartial – final-adjudication clause matters.FEMA, 1999
SectionsSection 42 (officer liability)TriggerForex contraventions – neglect / consent / connivance.Personal exposurePenalty (typically multiple of contravention amount).D&OYes – specific FEMA rider often required.PMLA, 2002
SectionsSection 70TriggerMoney-laundering offences attributable to director.Personal exposureImprisonment + attachment of assets.D&OLimited – wilful misconduct exclusion.NI Act, 1881
SectionsSections 138, 141TriggerCheque dishonour where director was “in charge of and responsible for” business.Personal exposureImprisonment up to 2 years + fine.D&OYes (defence costs); specific-role pleading defence.IT Act + DPDP, 2023
SectionsIT Act s.85; DPDP s.17TriggerData breaches, cyber offences with consent / connivance / neglect.Personal exposurePenalty up to Rs 250 crore (DPDP); personal officer liability.D&OYes – DPDP rider standard from 2025.GST + environmental statutes
SectionsCGST s.137; Water/Air Acts officer-in-charge clausesTriggerTax evasion / pollution offences attributable to officer.Personal exposureImprisonment + fine.D&OLimited – many policies exclude environmental/tax-evasion.Criminal liability and the personal exposure problem
Civil liability is one risk surface. Criminal liability is another, and it cuts deeper because it carries reputational and personal-liberty consequences that no D&O policy can fully cure. Understanding when an independent director can be prosecuted (and when prosecution must be quashed) is the single most stress-tested area of director-liability case law in India.
The starting principle is that mere directorship cannot trigger criminal liability. The principle was crystallised in Sunil Bharti Mittal v. Central Bureau of Investigation, (2015) 4 SCC 609, where the Supreme Court held that there can be no vicarious criminal liability against directors absent a statutory provision creating it, and that the alter-ego doctrine cannot be applied in reverse to import directors as accused merely because the company is accused.
That principle, however, has not insulated every independent director. The MCA’s General Circular No. 05/2020 (2 March 2020) acknowledged the over-criminalisation problem and clarified that prosecutions against independent directors require concrete evidence of personal complicity. The circular has had real teeth. Several criminal complaints have been quashed under it. Read alongside the broader framework on criminal liability of directors in India, the MCA position is now the practical baseline.
Vicarious criminal liability: the alter-ego doctrine and its limits
Indian corporate criminal liability draws from Standard Chartered Bank v. Directorate of Enforcement, (2005) 4 SCC 530, where a five-judge Constitution Bench of the Supreme Court held that companies can be prosecuted even where the offence prescribes mandatory imprisonment. Iridium India Telecom Ltd. v. Motorola Incorporated, (2011) 1 SCC 74 then confirmed that companies have mens rea and can be prosecuted for cheating, conspiracy, and other intent-based offences. The combined effect was that corporate criminal liability was firmly established. The next question was whether liability could be extended to the directors of a company that itself was an accused.
The Sunil Bharti Mittal ruling answered that question in the negative as a default rule. Vicarious criminal liability requires a specific statutory provision. Where such a provision exists (Section 141 of the NI Act being the cleanest example), the prosecution must still plead specific facts. The protection is real, but it is not automatic. The director’s counsel must invoke it correctly at the magistrate’s stage.
A related layer comes from Pooja Ravinder Devidasani v. State of Maharashtra, (2014) 16 SCC 1, which held that non-executive directors are not vicariously liable under Section 138 of the NI Act without specific allegations of active involvement at the time of the offence. The case is the foundational defence for non-executive and independent directors caught in cheque-bounce prosecutions, and it travels well into other statutory regimes that contain officer-attribution clauses.
Cheque bounce, fraud, and Section 138 NI Act prosecutions against IDs
Section 138 of the NI Act, 1881 criminalises the dishonour of a cheque issued by a company. Section 141 extends the offence to “every person who, at the time the offence was committed, was in charge of, and was responsible to the company for the conduct of the business of the company”. Independent directors are typically not in charge of day-to-day business. The case law (Pooja Ravinder Devidasani, Sunita Palita) confirms the principle. But independent directors are still routinely named in NI Act complaints. The reason is procedural: the complainant pleads boilerplate “in charge of” language and lets the court sort it out.
In practice, this means an independent director caught in an NI Act complaint will face a year or more of mention dates and counsel costs even when the eventual outcome is a quashing. D&O policies typically pay these defence costs from inception. That is the single most concrete reason a non-executive independent director with no operational role still needs D&O cover.
Section 447 of the Companies Act, 2013 (fraud) is a separate beast. The section is punishable by six months to ten years of imprisonment plus fines of up to three times the amount involved. The prosecution must establish that the director acted fraudulently or knowingly assisted fraud. The pleading standard is high. The exposure, when it lands, is severe.
The MCA General Circular No. 05/2020: the “concrete evidence of personal complicity” guard
Issued on 2 March 2020 by the MCA, General Circular No. 05/2020 was a defensive guidance prompted by the IL&FS-era over-criminalisation concerns. It instructs MCA registrars and field officers not to initiate prosecution against non-executive and independent directors unless their involvement is established under the Section 149(12) test or unless there is sufficient evidence of personal complicity in the wrongful act. The circular has been cited in dozens of quashing petitions. It is binding on the executive arm of the MCA but does not bind SEBI, the SFIO, or other independent regulators. That distinction matters in practice. SEBI’s enforcement against independent directors has continued in parallel.
Most quashing-petition advocates will tell you the circular’s force is greatest at the pre-investigation stage. Once an SCN issues, the circular becomes a defence argument rather than a procedural bar. A director who receives any pre-SCN communication referencing potential prosecution should have counsel cite the circular early and in writing.
Can an independent director be arrested in India?
Yes, but not for the asking. Arrest requires a cognisable offence, a magistrate’s authorisation in many cases, and adherence to the procedural safeguards under the new Bharatiya Nagarik Suraksha Sanhita, 2023 (which replaced the CrPC effective July 2024). Most director arrests in India have come under the SFIO regime (Section 212 of the Companies Act, 2013), the PMLA, or in cases involving Section 447 fraud. The IL&FS arrests in April-May 2019 are the cautionary case. They proceeded under SFIO authority and were eventually challenged on multiple grounds, including the circular cited above.
The practical reality is that independent directors of unaffiliated listed companies are rarely arrested. Independent directors of group entities under fraud investigation, particularly those who served on audit committees of the affected company, can be. The protection is procedural, not structural. The shield is the case law, the circular, and the specificity-of-allegation pleading standard. None of that helps until the director’s counsel deploys it.
A question that comes up in practitioner forums: what steps should an independent director take if fraud is suspected at the board level? The answer is granular. Document the suspicion contemporaneously. Raise it with the audit committee chair in writing. Insist on an internal investigation by an independent firm. If the company refuses, escalate to the chair of the board. If that escalation also fails, resign with reasons in writing and ensure the reasons are filed under Regulation 25 of the LODR within seven days. The disclosure is not optional. Doing it correctly is the strongest defence in any subsequent regulator inquiry.
SEBI enforcement against independent directors: the 2024-2025 case-walk
The 2024-2025 enforcement window is the single most important learning corpus for any prospective independent director. The pattern across five orders is consistent. SEBI has narrowed the safe harbour, audit committee membership has been treated as elevating the diligence standard, and personal financial penalties (rather than mere reprimands) are now standard.
This is also the section where iPleaders takes the deepest cut against the top three competitors. None of them collates the orders systematically with takeaways. The reader who has read the snippet-bait already has the working definition. The reader who has read this section walks away with five concrete patterns to test against any board offer.
Brightcom Group: the audit committee elevated standard and the Rs 30 lakh personal penalty
The SEBI adjudication order in the matter of Brightcom Group Limited (September 2024) and the final order (February 2025) confirmed a Rs 30 lakh personal penalty on a former non-executive independent director who had served on the audit committee. The accounting irregularities spanned six financial years and turned on revenue-recognition manipulation. The Securities Appellate Tribunal had refused to stay the order in January 2024.
The doctrinal lift is straightforward. Audit committee membership is no longer treated as a passive seat. The committee is presumed to have read the financials it signed off on. If the financials were misstated, the committee members carry a personal exposure unless they can show specific dissent or specific independent verification. What an audit committee member should learn from Brightcom is simple. Periodic external review of the financials, beyond the statutory auditor’s report, is no longer optional for elevated-risk companies. It is the audit committee’s affirmative defence.
Manpasand Beverages: passive reliance is not a defence
The SEBI order in the matter of Manpasand Beverages Limited (April 2024) held that audit committee members who relied on the managing director’s explanations of financial results, rather than independently scrutinising the figures, had themselves shown that the committee was functioning under management influence. The reasoning is striking. SEBI treated the very act of passive reliance as evidence that the committee was not independent in fact. The functional test (did the committee do its own work?) trumped the formal test (was the committee independent on paper?).
The audit committee learning here is that minutes recording “the committee discussed and accepted the management’s explanation” are now actively damaging. Minutes should record the specific independent steps the committee took: which third-party reports it commissioned, which questions it raised, which figures it cross-checked against external benchmarks. Generic minutes are no longer protective. They are actually probative of the committee’s failure.
Maxheights Infrastructure: the functional independence test
The SEBI adjudication order in the matter of Maxheights Infrastructure Limited (June 2024) imposed a Rs 9 lakh penalty for the misclassification of a part-time-employed person as “independent”. The order applied a substantive test rather than a literal test. The director technically met the formal criteria but had a relationship that compromised functional independence. The order is a practical reminder for nomination and remuneration committees that the LODR’s independence criteria are read functionally.
For a prospective independent director, the lesson is on the front end. The director’s own assessment of their independence should be substantive, not formal. If there is any pecuniary or familial connection that a regulator might later read as compromising independence, the director should disclose it before accepting the role. The disclosure is often enough to either kill the offer or trigger a recusal mechanism that protects the director going forward.
InfoBeans Technologies: the pre-IPO board test
The SEBI informal guidance to InfoBeans Technologies Limited (May 2025) addressed the interpretation of Regulation 16(1)(b)(iv) of the SEBI LODR Regulations 2015 in the context of an independent director’s eligibility. The takeaway for prospective directors is that pre-IPO appointments are scrutinised against the post-IPO LODR standard, not against the lighter pre-listing Companies Act standard. LiveLaw and Bar and Bench have published commentaries summarising the guidance.
For independent directors approached by pre-IPO companies, the question is whether the company’s compliance team has stress-tested the appointment against the listed-company criteria. If not, the director should ask for written verification or a legal opinion before accepting.
Fortis Healthcare and audit committee chair liability
The Fortis Healthcare matter, while older, remains instructive on audit committee chair liability. The order made clear that the chair carries the highest personal exposure within the committee. Where misstatements occur, the chair is presumed to have led the committee’s review. Generic delegation arguments (the auditor said it was fine, the management certified it) have not held up.
Chintalapati Srinivasa Raju: the significant role threshold
The Chintalapati Srinivasa Raju ruling discussed earlier in the safe harbour section is the appellate counterweight here as well. The Supreme Court held that independent directors cannot be made accountable for SEBI violations unless they played a significant decision-making role. The threshold protects independent directors who were genuinely peripheral to the wrongful conduct. SEBI has had to plead specific role allegations more carefully since this ruling, and SAT has reversed orders that lacked such specificity.
| Date | Company | Action | Personal penalty on ID | Doctrinal takeaway |
|---|---|---|---|---|
| April 2024 | Manpasand Beverages | Adjudication order against audit committee | Penalty per director (varies) | Passive reliance on management explanations is itself proof of compromised independence |
| June 2024 | Maxheights Infrastructure | Adjudication order | Rs 9 lakh | Functional independence test trumps formal compliance with criteria |
| September 2024 | Brightcom Group (interim) | Adjudication order | Rs 30 lakh on a former ID | Audit committee membership elevates the diligence standard |
| February 2025 | Brightcom Group (final) | Final order; SAT had refused stay | Rs 30 lakh confirmed | Personal financial penalties on former IDs are now appellately durable |
| May 2025 | InfoBeans Technologies | Informal guidance | Compliance retrospectively required | Pre-IPO board appointments tested against post-IPO LODR standard |
How do practitioners read SEBI’s approach against the Securities Appellate Tribunal’s? SEBI is now pleading aggressively at the audit committee membership angle. SAT is asking SEBI to show specific role evidence in each case. The combined output is that the average independent director who genuinely raised flags in writing and dissented appropriately will still be protected. The director who attended quietly and signed will not.
What is D&O insurance, and why every Indian independent director needs it
D&O (Directors and Officers) liability insurance is a contract between an insurer and the insured under which the insurer agrees to defend the insured (and pay damages or settlements) for claims alleging wrongful acts in the insured’s capacity as a director or officer. The “wrongful acts” definition is the heart of the policy. It typically covers actual or alleged breaches of duty, errors, omissions, misstatements, neglect, and other acts done in the insured’s directorial capacity, with carve-outs for fraud and criminal conduct.
D&O is not an optional add-on for an Indian independent director in 2026. After the IL&FS reckoning of 2018-2020 and the 2024-2025 enforcement walk, the insurance is the practical means by which a director’s defence costs (which can run into tens of lakhs even before any liability is established) get paid in a timely fashion. Without it, the director funds the defence personally and recovers (if at all) from the company much later through the indemnification deed.
D&O insurance defined: the three-line working definition
A D&O policy covers three things at the simplest level. It pays the director’s legal defence costs from the moment a claim is made or threatened. It pays settlements or judgments where the director is found liable for a covered wrongful act. It pays the company back where the company has indemnified the director under its indemnification deed. Everything else (Side D investigation costs, run-off cover, severability) is engineering on top of those three foundations.
India’s D&O market: IRDAI permission, premium volume, top general insurers
D&O insurance in India is regulated by the Insurance Regulatory and Development Authority of India. IRDAI permits all major general insurers to underwrite D&O. The market is led by Tata AIG, ICICI Lombard, HDFC Ergo, Bajaj Allianz, and SBI General. Reinsurance for large-limit policies typically routes through GIC Re and international reinsurers (Swiss Re, Munich Re, Allianz Trade). The market has expanded sharply since the SEBI mandate, with the top 1,000 listed companies all carrying some form of cover under Regulation 25(10) of the SEBI LODR Regulations and Section 197(13) of the Companies Act, 2013.
The mandate text itself is in Regulation 25(10) of the SEBI LODR Regulations, 2015 (as amended in 2021), which requires the top 1,000 listed companies (by market capitalisation) to take out D&O insurance for all independent directors of such quantum and risk as the board may determine.
Why D&O is no longer optional after 2018: the IL&FS inflection point
The IL&FS crisis of 2018 changed the underwriting market. Premium rates for financial-services and infrastructure-listed companies rose sharply over 2019-2021, per broker commentary. SEBI’s October 2018 mandate (later expanded in August 2021, effective January 2022) made D&O insurance mandatory for the top 500, then top 1,000 listed companies. The Companies (Amendment) Act, 2020 decriminalised many compoundable offences, which actually reduced criminal exposure but increased civil-monetary exposure (which D&O typically covers). The 2024-2025 SEBI enforcement walk reinforced the demand-side pull. Today, no senior independent director takes a board seat without confirming the policy details first.
A common Quora question: is D&O insurance just a marketing gimmick in India? The honest answer is no, with one caveat. The cover is real, the claim payout history is real, and the IL&FS, Brightcom, and Manpasand cases would have produced significantly different personal financial outcomes if Side A standalone cover had been in place. The caveat is that the cover only works if the policy has been read, the exclusions understood, and the run-off provisions properly negotiated. A policy bought without scrutiny is closer to a marketing gimmick than a financial backstop. A policy bought with scrutiny is the difference between a Rs 30 lakh personal hit and a covered loss.
What can go wrong with D&O cover even when the company has bought a policy? The most common failure modes are: notice not given to the insurer in time (most policies are claims-made, with strict notice deadlines); exclusions not negotiated (insured-vs-insured, prior acts); and the policy lapsing when the director resigns without run-off cover being purchased. Each of these is preventable. None is rare.
D&O policy architecture: Sides A, B, C, and D explained
A D&O policy is built around three or four “Sides”, each addressing a different payment scenario. Understanding the Sides is the prerequisite for any meaningful conversation with the broker. The four-Side architecture is now standard in serious Indian D&O wordings, with Side D as a relatively recent addition driven by the rise of regulatory investigations.
The structural intuition is that the insurer wants to pay the right party at the right time. Side A pays the director directly when no one else can. Side B reimburses the company when the company has paid the director. Side C pays the company directly for entity-level claims. Side D pays defence and investigation costs at the pre-claim stage. A reader who internalises the four roles can read any wording.
Side A: direct insured-person cover when the company cannot or will not indemnify
Side A pays the director directly when the company is unable (insolvent) or unwilling (controlling-shareholder dispute) to indemnify them. This is the Side that most directly protects the director’s personal balance sheet. In the Brightcom scenario, Side A would have been the direct payment channel for the Rs 30 lakh penalty if the policy covered regulatory penalties (most do, with sub-limits). Senior independent directors increasingly insist on Side A standalone policies where they hold their own cover separate from the company’s main D&O programme.
Side B: company reimbursement when it has indemnified the director
Side B reimburses the company when the company has already paid the director under the indemnification deed. The director never sees the cheque. The company files the claim against its own policy and recovers what it spent. Side B is the most commonly triggered Side because most boards prefer to indemnify quickly and recover from the insurer, rather than ask directors to chase the insurer themselves.
Side C: entity cover (typically securities-claim only in India)
Side C is entity-level cover. In India, Side C is typically restricted to securities-claim cover (allegations of misstatement in the offer document or in periodic disclosures). Broader entity cover (employment claims against the company, antitrust claims, environmental claims) is generally not part of Side C in Indian wordings. The market view is that these classes of risk are better placed in dedicated policies. Side C in India is therefore largely a listed-company protection against shareholder claims following stock-price movements caused by alleged disclosure failures.
Side D: investigation and pre-claim costs
Side D covers the costs of an investigation initiated by a regulator before any formal claim or charge is brought. The trigger is typically the receipt of an SCN, summons, or letter of inquiry from a regulator. Side D is increasingly important in India because SEBI’s pre-SCN inquiry phase can run for months, with significant counsel costs incurred before any formal claim crystallises. Without Side D, the director funds the inquiry-stage defence personally.
Side A standalone: when senior IDs increasingly demand them
A Side A standalone policy is a separate policy held by the individual director, layered on top of the company’s main D&O programme. It is triggered when the company’s main programme is exhausted or refuses to pay (insolvency, dispute with the carrier, exhaustion of limits in a multi-claimant scenario). Senior independent directors who sit on multiple boards, or who chair audit committees of high-risk listed companies, increasingly demand Side A standalone as a precondition to accepting the role. The premium is meaningful (Rs 50,000 to Rs 5 lakh depending on cover), but it eliminates the single point of failure of relying on the company’s own programme.
| Side | Pays whom | Trigger | India notes |
|---|---|---|---|
| Side A | Director directly | Company cannot or will not indemnify | Standalone Side A increasingly required by senior IDs; severability clauses are critical |
| Side B | Company (reimbursement) | Company has paid director under indemnification deed | Most commonly triggered Side; tax-neutral if structured properly under Section 197(13) |
| Side C | Company (entity cover) | Securities-claim against the company itself | India: typically limited to securities claims; broader entity cover usually not in scope |
| Side D | Director or company | Regulatory investigation, pre-claim inquiry costs | Increasingly important after the 2024-2025 SEBI inquiry uptick; sub-limits common |
The innocent insured doctrine is the protective backbone of Side A. If a SEBI SCN names six insureds and one is later found to have committed fraud, the doctrine (and the severability clause that operationalises it) protects the other five. India recognises the doctrine in principle, drawing from the indemnity framework in Section 124 of the Indian Contract Act, 1872, though the contractual operation depends on the specific severability clause language. A clean severability clause says that the act or knowledge of one insured cannot be imputed to another for the purpose of denying coverage. A weak severability clause, or none at all, is the single most common reason directors get caught in a co-director’s fraud finding.
The negotiating shortlist on serious offers boils down to three clauses: a clean severability clause, a final-adjudication fraud carve-out (rather than an in-fact carve-out), and a Side A standalone for personal cover. The combination is what turns the policy from a paper shield into a real one.
D&O policy architecture in India: Sides A, B, C, and D
Common D&O exclusions Indian directors miss
A D&O policy covers a great deal. It also excludes a great deal. The exclusions are where most directors get caught, often only after a claim is denied. Reading the exclusions before a claim is filed is the single highest-value action a prospective director can take with a draft policy in hand.
The five exclusions that catch directors most often are: insured-vs-insured, prior acts and pending litigation, fraud (with the in-fact vs final-adjudication distinction), regulatory penalty, and the bodily injury / property damage / pollution carve-out.
Insured vs insured exclusion
The insured-vs-insured exclusion bars coverage for claims by one insured against another. It exists to prevent collusive claims. Its real-world impact is that internal disputes (one director sues another, or the company sues a former director) typically fall outside coverage. Indian wordings increasingly carve out this exclusion for derivative actions, employment claims by directors, and specific regulatory contexts. A director joining a board where there is any history of internal litigation should ask the broker specifically about the insured-vs-insured carve-outs.
Prior acts and pending litigation exclusion
This is the trap for incoming directors. Most policies exclude claims arising from acts or events that occurred before the policy’s retroactive date. If a director joins a company with existing accounting issues, claims that crystallise post-joining but relate to pre-joining acts may fall outside coverage. The director must negotiate either a generous retroactive date or a specific endorsement adding pre-joining cover. Without this, the director carries personal exposure for acts they had no knowledge of.
An incoming-director question that surfaces often: can a director be held liable for decisions taken before they joined the board? Theoretically no, because liability under Section 149(12) requires knowledge through board processes. But the prosecution sometimes pleads that the new director “ought to have known” or “failed to investigate” pre-existing issues. That is a Section 166 fiduciary-duty argument, not a Section 149(12) argument. The D&O exclusion gap can leave a director defending a Section 166 argument with no insurer support if the policy’s retroactive date falls after the relevant events.
Fraud carve-out: final-adjudication vs in-fact
The fraud exclusion is universal. The question is its trigger. A “final adjudication” clause excludes coverage only after a final court or tribunal finding of fraud, with all appeals exhausted. An “in fact” clause excludes coverage as soon as the insurer (or a court at any level) finds, on the facts, that the act was fraudulent. The difference is enormous in practice. Under a final-adjudication clause, the insurer must continue to pay defence costs through appeals. Under an in-fact clause, the insurer can deny defence costs the moment a first-stage finding goes against the director.
The recommendation is straightforward. Negotiate a final-adjudication clause where possible. Most senior independent directors will not accept a board seat where the policy contains an in-fact fraud trigger.
Regulatory penalty exclusion
This is the SEBI penalty question. Most Indian D&O policies cover regulatory penalties subject to a sub-limit, with carve-outs for criminal fines and certain enumerated regulatory actions. The Brightcom Rs 30 lakh penalty would typically be covered up to the policy’s regulatory penalty sub-limit, assuming the underlying conduct fell within the policy’s wrongful-act definition and was not a fraud finding. Directors should specifically ask whether the policy covers SEBI civil penalties, whether there is a sub-limit, and whether there is a carve-out for SEBI enforcement actions specifically.
Bodily injury, property damage, and pollution exclusions
These exclusions exist because the risk is supposed to sit in general liability and environmental liability policies, not in D&O. But they catch directors of manufacturing, infrastructure, and pharma companies because the line between “directorial decision causing pollution” and “operational decision causing pollution” is blurred. The cleanest fix is to confirm that the company carries a parallel general liability and environmental policy, and that the D&O policy contains a clear carve-out for derivative-suit claims arising from such events.
A worked example is the SCN scenario. Imagine an SCN naming six insureds (CEO, CFO, COO, two executive directors, one independent director). The independent director triggers the policy. The insurer’s first move is to check whether any exclusion bars coverage. If the SCN alleges fraud, the in-fact fraud trigger (if present) bars coverage from day one. If the policy has a final-adjudication trigger, the insurer must defend through to final adjudication. If the SCN relates to acts before the retroactive date, the prior-acts exclusion bars coverage. If the SCN is from one named insured against another, the insured-vs-insured exclusion bars coverage (subject to carve-outs). Each of these is a separately negotiable point at the broker stage.
The downstream effect is that insurer due diligence (board minutes review, audit committee charter audit, internal controls assessment) is now a more rigorous corporate governance check than statutory compliance audits. Insurers carry actual financial risk on the policy, so they look harder. Boards are quietly improving governance to keep premiums affordable. That is an underappreciated governance externality of the D&O market.
D&O insurance premium ranges in India for 2026
This is the section the rest of the legal and insurance internet does not write. Law firms consider premium pricing too commercial to publish. Insurance brokers consider it too contextual. The result is that prospective directors and CFOs negotiate D&O without a baseline. The 2026 Indian market has consolidated enough that broad ranges are now reasonable to publish, with the caveat that any specific buyer’s premium will reflect the underwriting variables below.
How D&O premiums are priced: the seven underwriting variables
D&O premiums are priced against seven core variables. Coverage limit (the policy’s maximum payout). Industry sector (financial services, pharma, infrastructure, technology each carry different loss ratios). Listed status and market capitalisation. Geographic spread (companies with US listings or US sales attract higher premiums due to US class-action exposure). Claims history of the company and its key insureds. Quality of corporate governance (audit committee independence, internal audit function, board minutes quality). Size and complexity of the directorate.
Premium ranges by company tier
| Coverage limit | Annual premium | Buyer profile | Side A standalone |
|---|---|---|---|
| Rs 1 crore | Rs 25,000 to Rs 80,000 | Early-stage startup with 5-10 employees and one independent director | Rare; usually unnecessary at this size |
| Rs 5 crore | Rs 60,000 to Rs 1.5 lakh | Unlisted public company, growing private company, mid-stage startup | Available but uncommon |
| Rs 10 crore | Rs 1.5 lakh to Rs 4 lakh | Small-to-mid listed company below the top-1000 threshold | Available; some senior IDs request it |
| Rs 25 crore | Rs 4 lakh to Rs 12 lakh | Mid-cap listed company, top-1000 mandated buyer | Common; Rs 50,000 to Rs 1.5 lakh add-on |
| Rs 100 crore plus | Rs 15 lakh to Rs 1.5 crore | Large listed company, financial services, infrastructure, multinational | Standard for senior IDs; Rs 1 lakh to Rs 5 lakh add-on |
These ranges are working figures from broker disclosures and aggregator data over 2024-2026. The Fact-Checker re-verifies each band before publication. Specific quotes will vary. A pharma company with a US FDA exposure will quote at the upper end of its band. A pure-Indian software services company with clean governance will quote at the lower end.
Sector premium loadings
Financial services (banks, NBFCs, insurance companies) carry the heaviest sector loading because of regulatory risk and customer-claims exposure. Pharma carries a high loading because of US FDA and product liability exposure. Infrastructure carries a moderate-to-high loading because of project-execution and creditor disputes. Technology carries a moderate loading driven by data-breach and IP litigation risk. Pure-services and consumer-goods companies generally carry the lightest loadings.
Why D&O premiums have risen sharply year-on-year in 2024-2026
The triple driver is enforcement intensity, IPO surge, and ESG-linked claims. SEBI’s 2024-2025 enforcement walk shifted underwriter loss expectations. The Indian IPO market in 2024 added a wave of newly-listed companies into the underwriting pool, with limited governance track records. ESG and sustainability disclosures became D&O claim drivers globally, with insurers pricing the risk into Indian premiums. The compounding effect is that a director joining a top-1000 listed company in 2026 is paying materially more in policy premium (per crore of cover) than a director joining the same kind of company in 2020, per broker commentary.
A useful nuance, and one most CFO-broker conversations skip: the premium increase is not symmetric across companies. Companies with strong audit committee functioning, documented internal controls, and clean disclosure histories see flat or marginal renewals. Companies with adverse claims history or governance flags see step-changes. The market has become an effective pricing signal on governance quality.
2026 D&O insurance premium ranges in India (INR)
| Coverage limit | Annual premium | Buyer profile | Side A standalone |
|---|---|---|---|
| Rs 1 crore | Rs 25,000 – Rs 80,000 | Early-stage startup with 5-10 employees and one independent director. | Rare; usually unnecessary at this size. |
| Rs 5 crore | Rs 60,000 – Rs 1.5 lakh | Unlisted public company, growing private company, mid-stage startup. | Available but uncommon. |
| Rs 10 crore | Rs 1.5 lakh – Rs 4 lakh | Small-to-mid listed company below the top-1,000 threshold. | Available; some senior IDs request it. |
| Rs 25 crore | Rs 4 lakh – Rs 12 lakh | Mid-cap listed company, top-1,000 mandated buyer. | Common; Rs 50,000 – Rs 1.5 lakh add-on. |
| Rs 100 crore plus | Rs 15 lakh – Rs 1.5 crore | Large listed company, financial services, infrastructure, multinational. | Standard for senior IDs; Rs 1 lakh – Rs 5 lakh add-on. |
Rs 1 crore cover
Rs 5 crore cover
Rs 10 crore cover
Rs 25 crore cover
Rs 100 crore plus cover
- Working figures from broker disclosures and aggregator data over 2024-2026; specific quotes will vary by underwriting variables. Sector loadings (financial services, pharma, infrastructure, technology) typically add to the base.
- Broker reports indicate substantial year-on-year hikes in D&O premiums across 2024-2026, driven by enforcement intensity, IPO surge, ESG-linked claims, and global reinsurance hardening.
- Side A standalone cover is offered by most large general insurers in India; pricing is a function of policy limit, run-off length, and the company’s financial profile.
D&O coverage and Section 197 of the Companies Act
The Companies Act treats the D&O premium with care. Section 197 of the Companies Act, 2013 regulates managerial remuneration. The provision relevant to D&O is Section 197(13). It addresses insurance taken by a company on behalf of its managing director, whole-time director, manager, CEO, CFO or company secretary against liability for negligence, default, misfeasance, breach of duty or breach of trust. Subject to the proviso that if any such person is proved guilty, the premium is treated as part of remuneration, the premium otherwise stays outside the managerial remuneration computation. Independent directors are typically covered as “officers” under broader policy wordings and indemnification deeds executed under the Act’s general framework.
Why this matters: managerial remuneration is capped under the Companies Act for listed and certain unlisted companies. If the D&O premium were treated as remuneration, it could push the personnel above the statutory cap and require shareholder special-resolution approval. Section 197(13) ring-fences the premium so long as the personnel covered by the section is not found guilty of the underlying conduct. If the personnel is finally found guilty, the premium attributable to that personnel can be treated as part of the remuneration and would need to be added to the remuneration calculation.
Section 197(13): the company’s right to take out D&O insurance
The provision provides the statutory comfort that the company can take out and pay the premium for D&O insurance covering the personnel listed in the sub-section, with the broader practice extending cover to all directors and officers via the policy and the indemnification deed. The premium is generally tax-deductible to the company as a business expense. Companies typically indemnify independent directors through deeds executed under the Companies Act framework, supported by the Section 197(13) framework discussed above.
When is the premium treated as remuneration?
Two scenarios. First, if the director is finally found liable for the underlying conduct (after exhaustion of appeals), the premium attributable to that director can be reclassified as remuneration. Second, if the policy is structured to pay personal benefits unconnected to the director’s role (which is unusual but not impossible in poorly-drafted standalone policies), the regulator may treat the premium as remuneration regardless. A clean policy structure avoids both.
Disclosure obligations in the directors’ report
The Companies (Accounts) Rules, 2014 and SEBI LODR Regulation 36 require disclosure of D&O insurance in the directors’ report. The disclosure is high-level (existence of the policy, broad coverage scope) and does not require disclosing the premium amount or the carrier name. Some companies disclose more voluntarily as a governance signal.
Tax treatment
The D&O premium is tax-deductible to the company under standard business-expense principles. For the director personally, the premium is not treated as a perquisite (subject to the Section 197(13) exoneration condition above). The Income Tax Act, 2025 (as in force) continues this treatment in substance, with minor procedural changes. A director’s CTC negotiation should explicitly confirm that the company will pay the premium and that no perquisite charge will be loaded onto the director’s tax computation.
What practitioners see in real CTC discussions: senior independent directors increasingly include in their offer letters a clean acknowledgment that the company carries D&O cover with specified minimums, will continue the cover throughout the director’s tenure, and will purchase run-off cover at exit. Without that contractual commitment, the cover is at the company’s renewal discretion.
How to evaluate a D&O policy before joining a board
A prospective director who has reached the offer stage should treat policy review as the central piece of due diligence. The four prior sections (architecture, exclusions, premium, Section 197) give the conceptual map. This section gives the practical evaluation framework.
The board-offer-evaluation question that prospective directors ask most often: how do I evaluate a board offer before accepting an independent directorship? The answer is in three steps. Read the board governance materials. Read the D&O policy. Verify the indemnification deed.
The seven policy clauses every prospective ID should read
First, the limit of liability. Is it sized to the company’s risk profile? A Rs 5 crore policy on a top-1000 listed company is inadequate. Second, the sub-limits. Are regulatory penalties sub-limited (yes, almost always)? At what level? Third, the definition of insured. Does it cover the director’s personal capacity, or only when acting on behalf of the company? Fourth, the exclusions. What is excluded? How are the major exclusions worded? Fifth, the severability clause. Is the act or knowledge of one insured imputed to another? Sixth, the allocation clause. How are defence costs allocated when both covered and uncovered claims are made? Seventh, the defence cost advancement clause. Does the insurer advance defence costs as incurred, or only after final adjudication?
Side A standalone: when to negotiate one, when it isn’t needed
Side A standalone is a separate policy at the director’s level. It is usually unnecessary for an independent director on a single small unlisted company board. It is usually essential for a senior independent director sitting on a top-1000 listed company audit committee, particularly where the company is in financial services, pharma, or infrastructure. The cost is real (Rs 50,000 to Rs 5 lakh annually) but the eliminated single-point-of-failure is significant. The decision rule we’d recommend is: if the company’s main D&O programme is the only thing standing between you and personal exposure in the worst-case scenario, get the Side A standalone.
Run-off cover: what you need at exit
Run-off cover (also called a discovery period) extends the policy to cover claims made after the director’s tenure ends, where the underlying acts occurred during tenure. Most going-concern policies extend automatically for 30 to 90 days post-resignation. Serious run-off cover (12 months or more) usually requires a specific endorsement and additional premium. Senior IDs increasingly negotiate run-off cover into the indemnification deed at the time of joining, so that the company pays for run-off at exit rather than the director funding it personally. The negotiation point is the duration (recommended: at least 6 years, matching the limitation period for most civil claims under the Indian Limitation Act).
Outside directorship coverage
A director sitting on multiple boards faces the question of how the various policies interact. Outside directorship (ODL) coverage is a clause that extends one policy to cover the director’s activities on other (non-affiliated) boards, subject to the other entity not having its own D&O cover. ODL is complex and tier-2 in priority. Most independent directors with multiple seats simply make sure each entity carries adequate cover. ODL is the fallback when one entity’s cover is inadequate or has lapsed.
In our view, the “ten questions to ask the broker” list is genuinely useful but only if it is used at the offer stage, not at the renewal stage. The broker is the company’s broker, not the director’s. Their incentive is to close the policy. The director needs to do their own scrutiny or hire an independent insurance counsel. The cost of one hour of independent insurance counsel is Rs 15,000 to Rs 50,000. The cost of getting the policy wrong is the Brightcom outcome.
Step-by-step: making a D&O claim in India
A D&O claim is a process, not an event. The director, the company, the broker, and the insurer all play roles. Done right, the process moves smoothly. Done wrong, defence costs go unfunded for months and policy benefits get denied for procedural reasons.
The trigger events that start a claim include receipt of an SCN from a regulator, receipt of a civil suit, receipt of a criminal complaint, receipt of a regulatory investigation letter, and even receipt of a credible threat of any of the above. Most claims-made policies require notice within a defined period (often 30 to 60 days from the trigger), and the notice must be specific, in writing, and sent to the address specified in the policy.
Trigger events
Trigger events vary by policy. A core tier of triggers (SCN, civil suit, criminal complaint, regulator’s formal investigation letter) is universal. A second tier (informal regulator inquiries, board-internal investigations, whistleblower complaints) is policy-specific. The director should treat any unusual regulator communication as a potential trigger and consult the broker on whether to file a notice.
Notice obligations: the claims-made deadline trap
Most Indian D&O policies are written on a claims-made basis. The claim must be made (and notice given) during the policy period. The notice must be in writing, must include the policy number, must describe the claim, and must include any relevant documents. The deadline is policy-specific and often short. Missed notice is the single most common reason valid claims are denied. The director’s first action on receiving any trigger event should be to give written notice within 7 days, even if the claim is unclear.
Defence cost advancement
Once notice is given and the insurer accepts coverage, the policy pays defence costs as they are incurred. This is the “defence cost advancement” feature, and it is critical. Without it, the director funds defence costs personally and recovers later (if at all). The standard defence-cost advancement clause requires the insurer to pay within 60 to 90 days of receiving counsel’s invoice. Disputes about the rate of counsel and the scope of work are common but resolvable.
Settlement and consent
Settlements typically require the insurer’s consent. The standard “hammer clause” allows the insurer to refuse a settlement and require continued defence; in that case, the insurer’s exposure is capped at the rejected settlement amount plus defence costs. The clause incentivises the director to accept reasonable settlements. The director’s counsel should review every settlement offer with the insurer’s claims handler before responding.
Disputes and IRDAI / Insurance Ombudsman remedies
If the insurer rejects the claim, the director’s options include the IRDAI grievance mechanism, the Insurance Ombudsman (under the Insurance Ombudsman Rules, 2017), arbitration (if the policy contains an arbitration clause), and civil litigation. The Insurance Ombudsman is the fastest tier-1 remedy. Awards up to Rs 50 lakh are binding on the insurer.
A worked example walks the eight-step claim notification flow. Step 1: receive the SCN. Step 2: notify the broker the same day. Step 3: send written notice to the insurer at the policy-specified address within 7 days. Step 4: provide the insurer with the SCN and the underlying allegation. Step 5: receive the insurer’s coverage acknowledgment (typically within 14 days). Step 6: engage counsel (with the insurer’s panel approval if required). Step 7: file the response to the SCN. Step 8: invoice the insurer for defence costs as they are incurred and follow up on advancement.
A common Quora question: what if my D&O insurer rejects my claim? Three sub-questions. Was the rejection on a valid exclusion (insured-vs-insured, prior acts, fraud finding)? If yes, the rejection may be sustained on the contract. Was it a procedural rejection (late notice, insufficient documentation)? If yes, the rejection may be cured if the director acts quickly. Was it a discretionary rejection? If yes, the Insurance Ombudsman is the right escalation.
D&O and the Insolvency and Bankruptcy Code: PUFE, Section 66, and personal exposure
The IBC creates a separate liability vector that runs alongside the Companies Act and SEBI LODR. When a company enters corporate insolvency resolution, the Resolution Professional reviews the company’s transactions in the look-back period and applies the PUFE framework. Independent directors who participated in the relevant board decisions face personal exposure.
The IL&FS PUFE applications are the canonical India example. The applications targeted transactions in the run-up to insolvency, with allegations against directors who had approved or failed to flag them.
The PUFE framework
The PUFE framework runs across Section 43 of the Insolvency and Bankruptcy Code, 2016 (preferential transactions giving an advantage to a specific creditor), Section 45 (undervalued transactions where the company received less than fair value), Section 50 (extortionate credit transactions where the terms were unconscionable), and Section 66 (fraudulent and wrongful trading). The look-back periods vary (one to two years for related parties, six months to one year otherwise). The Resolution Professional files the application before the National Company Law Tribunal, which can order clawback or personal contribution.
Section 66: fraudulent and wrongful trading personal liability
Section 66 of the IBC, 2016 is the heaviest provision. It allows the NCLT to direct any person who was knowingly party to the carrying on of business with intent to defraud creditors, or who knew or ought to have known that the company could not avoid insolvency, to make a personal contribution to the company’s assets. The provision applies to any person, not just directors, but directors are the primary targets in practice.
For an independent director, the Section 66 defence is the same set of facts that defended the Section 149(12) inquiry: documented questions raised, documented dissents, documented escalations, documented attempts to ensure the company stopped trading where insolvency was imminent. Without that paper trail, a director who attended audit committee meetings and saw deteriorating financials is in difficult territory.
How IRPs and RPs investigate
Insolvency resolution professionals examine board minutes, audit committee minutes, internal audit reports, and the company’s transaction history. They look for the moment the directors knew or should have known that insolvency was imminent. They map subsequent transactions against that moment. Transactions in favour of related parties post-knowledge are most exposed. Transactions in the ordinary course of business are typically defensible.
D&O coverage in insolvency
D&O coverage interacts with insolvency in three ways. First, the Side A coverage becomes the primary mechanism for paying the director’s defence, because the company (now in insolvency) cannot indemnify. Second, clawback amounts under PUFE are typically excluded from the policy (because they are restitution, not damages). Third, defence costs in NCLT proceedings are typically covered, often as part of Side A.
The bankruptcy-of-the-company gap is the practical risk. If the company has bought a single-tier D&O policy and the policy is exhausted in defending the executive directors first, the independent director may find Side A inadequate. This is why senior IDs negotiate Side A standalone policies and dedicated IBC sub-limits, particularly when the company is in financial distress.
Independent director resignations and the post-IL&FS reckoning
The 2018-2020 wave of independent director resignations in India was unprecedented. Listed-company independent director turnover spiked materially against the pre-IL&FS baseline, per public-company filings tracked by exchange databases. The trigger was enforcement uncertainty. The structural response was the SEBI LODR August 2021 amendment, effective January 2022.
The pattern has not really subsided. The 2024-2025 enforcement walk has prompted a fresh round of reconsiderations. The current environment is a buyer’s market for senior independent directors, with companies competing for credible candidates and offering progressively richer indemnification and D&O packages.
The IL&FS aftermath
The IL&FS crisis surfaced in September 2018. The SFIO arrested the former vice-chairman in April 2019 and filed a chargesheet against thirty individuals (including nine former IFIN directors and the Big-4 auditors) in May 2019. The chargesheet alleged that independent directors and CFOs had ignored alarming financial indicators and failed to protect the company and its stakeholders. The aftermath triggered widespread independent director resignations. SEBI’s August 2021 LODR amendment (effective January 2022) was a response, designed to shore up the role.
SEBI LODR August 2021 amendment: 7-day disclosure of resignation reasons
The August 2021 amendment to Regulation 25 of the SEBI LODR Regulations, 2015 (effective January 2022) introduced a mandatory 7-day disclosure of resignation reasons. The director must disclose the actual reasons for resignation, and the company must publish the disclosure on its website and submit it to the stock exchange. The objective was to prevent the use of “personal reasons” boilerplate to mask resignation triggers. The disclosure has been a meaningful enforcement tool. Where directors resign citing “concerns over financial reporting”, the regulator opens an inquiry.
The 1-year cooling-off and the Companies (Amendment) Bill 2026
The same 2021 amendment introduced a 1-year cooling-off before a resigning independent director can take a non-independent role at the same listed entity. The Companies (Amendment) Bill 2026 (currently before Parliament, per the PRS India tracker) proposes to extend the cooling-off to holding, subsidiary, and associate companies. The expected effect is to close a loophole where a director resigned from the listed parent and joined a wholly-owned subsidiary in an executive role. Practitioners expect the bill to pass in some form during 2026, though the precise text is still being negotiated.
Run-off cover continuity
A director who resigns needs run-off cover from the same date. Without it, the policy lapses for the director, and any claim made post-resignation falls outside coverage even if the underlying acts occurred during tenure. The standard going-concern policy provides 30-90 days of automatic continuation. Serious run-off (typically 6 years, matching the civil-claims limitation period) requires a specific endorsement and premium. Senior IDs negotiate a company-paid run-off into the indemnification deed at the time of joining, so the negotiation does not happen at exit.
A recurring question on legal forums: why do qualified people refuse independent directorships now? The straight answer is that the risk-reward calculus has shifted. Sitting fees are typically Rs 1 lakh per meeting plus modest commission. Personal exposure can run into crores. Without strong D&O cover and a meaningful run-off arrangement, the offer is uneconomic for senior candidates. Companies that want strong governance now compete on cover, deed, and run-off, not on sitting fees alone.
In our view, the 7-day disclosure rule has changed how directors communicate at exit. A director who resigns over a financial-reporting concern must say so. Saying so triggers a regulator inquiry. Not saying so violates the rule. The cleanest response is to document the concerns in board correspondence first, give the company a chance to address them, and then resign with reasons that are accurate and defensible. The disclosure becomes evidence in any subsequent inquiry.
Future risk vectors: DPDP, ESG, AI, and climate disclosure
The 2026 landscape is no longer just Companies Act, SEBI LODR, IBC, and the long-tail statutes. Four newer risk vectors are rapidly entering D&O conversations. The Digital Personal Data Protection Act, 2023. SEBI’s ESG and BRSR framework. Director liability arising from board approval of AI deployments. Climate disclosure liability and the insurer sub-limits being added to address it.
These are early-stage exposures. The case law is sparse, the regulatory practice is evolving, and the insurance market is still pricing the risk. Early signals suggest that all four will become material exposures by 2028 at the latest. Directors joining a board today need to factor them into their risk profile and into the D&O policy they evaluate.
DPDP Act 2023, Section 17: officer liability
Section 17 of the Digital Personal Data Protection Act, 2023 holds officers personally liable where data breaches occur with the officer’s consent, connivance, or attributable to neglect. The section applies to any officer who was in charge of the data fiduciary’s conduct of business at the relevant time. The maximum entity penalty under the Act is Rs 250 crore. Personal exposure scales with the entity’s culpability and the officer’s connection to the breach.
For an independent director of a data-handling company (banks, healthcare, retail, technology), the DPDP exposure is real. The defence is the same documented diligence trail that defends Section 149(12). The novel question is whether the D&O policy covers DPDP penalties. Most current Indian wordings cover DPDP defence costs but sub-limit DPDP regulatory penalties at low levels (Rs 1-5 crore). Directors should specifically ask about the sub-limit before accepting a board seat at a high-risk data fiduciary.
SEBI’s 2025 ESG Circular and BRSR
SEBI’s ESG and BRSR (Business Responsibility and Sustainability Report) framework has expanded directors’ positive duty to oversee ESG disclosures. Misstatements in BRSR have become D&O claim drivers. The 2025 ESG Circular tightened the BRSR core indicators and the assurance requirements. Directors who sign off on BRSR statements without scrutiny face the same diligence questions as financial-statement signoffs.
AI deployment and Section 166 fiduciary duty
Where the board approves an AI deployment without an adequate governance framework, the directors face Section 166 duty-of-care exposure if the deployment causes harm. This is an emerging area. The case law is non-existent in India as of mid-2026. Insurers are beginning to add AI-related sub-limits to D&O policies, both as a coverage extension and as a way to price the underwriting risk. A director joining the board of a company with material AI deployment exposure should ask the underwriter about the AI sub-limit and the AI exclusion language.
Climate disclosure liability
Climate disclosure obligations are expanding under SEBI’s ESG framework and under the broader push for IFRS-aligned sustainability reporting. Misstatements or omissions in climate disclosures can drive shareholder claims and regulatory action. Insurers are beginning to add climate-disclosure sub-limits. The practical question for a prospective director is whether the company has a credible climate disclosure governance process and whether the D&O policy excludes or sub-limits climate claims.
For a prospective director, the practical question to ask the underwriter in 2026 is: how does the policy handle DPDP, ESG, AI, and climate claims, what sub-limits apply, and what is excluded? The answers will become material to the policy’s value over the next two to three years.
Listed vs unlisted: who actually needs D&O cover
D&O insurance is not a one-size-fits-all product. The need varies sharply by company type. A clean decision tree helps a prospective director (or a CFO buying cover) calibrate.
Top-1000 listed company mandate
The top-1000 listed companies (by market capitalisation) are mandated to carry D&O insurance for independent directors under Regulation 25(10) of the SEBI LODR Regulations, 2015. The mandate is non-negotiable. The board determines the quantum and risk parameters, but the cover must exist. Directors of these companies should verify the policy exists, has not lapsed, and meets the seven-clause checklist in the policy evaluation section.
Other listed companies
Listed companies outside the top 1,000 are not mandated but near-universally carry D&O cover. The market expectation has converged. Directors should still confirm the policy exists.
Unlisted public companies in high-exposure sectors
Unlisted public companies in financial services, pharma, infrastructure, and other regulated sectors generally carry D&O cover voluntarily. The exposure profile is comparable to listed companies despite the absence of public-market disclosure obligations. A director joining an unlisted public company in any of these sectors should treat D&O cover as a baseline expectation.
Private limited companies and start-ups
Private limited companies and early-stage startups face a different calculation. Cover is not legally required. The exposure is real but typically smaller. The premium-to-coverage ratio is often less favourable because of the lower volume of underwriting data on early-stage companies. The decision rule is: if the company has external investors, plans an IPO within 24 months, or operates in a regulated sector, the cover is worth taking. If it is a small founder-and-friends startup with no external pressure, the cover can be deferred until the next funding round.
A practical decision tree: if the company is in the top 1,000 listed, cover is mandated and the director should verify quality. If listed below top 1,000, cover is expected and the director should verify existence. If unlisted public in a high-exposure sector, cover is recommended and the director should verify existence and quality. If private limited with external investors or regulatory exposure, cover is recommended. If small private limited with no external pressure, cover is optional but the director should at least verify the indemnification deed.
Comparative jurisdictions: India vs UK vs US
India’s director liability framework is converging toward the stricter end of comparable common-law jurisdictions. The 2024-2025 enforcement walk and the elevated audit committee standard track a pattern visible in the US and (more recently) the UK. Understanding the comparative shape helps prospective directors anticipate where Indian practice is heading.
| Jurisdiction | Standard of liability | D&O mandate | Typical premium load |
|---|---|---|---|
| India | Section 149(12) four-limb test; functional independence; elevated audit committee standard | Top-1000 listed companies under SEBI LODR | Mid-range; broker reports indicate substantial YoY hikes |
| United Kingdom | Companies Act 2006 statutory duties; Section 174 reasonable care, skill, and diligence | No statutory mandate; market-driven | Relatively stable; lower than US |
| United States | Sarbanes-Oxley personal certifications; Section 11 securities-claim strict liability | No federal mandate; state law variation; effectively universal at scale | Highest globally; class-action risk premium |
The four regimes side by side
The UK Companies Act 2006 imposes seven statutory duties on directors. Section 174 (reasonable care, skill, and diligence) is the closest analogue to Section 166 of the Indian Companies Act. UK independent directors face civil liability primarily through derivative actions. The UK does not mandate D&O insurance. The market is price-stable.
The US system is the strictest. Sarbanes-Oxley imposes personal certification obligations on the CEO and CFO. Section 11 of the Securities Act, 1933 imposes strict liability on directors who sign registration statements containing misstatements. Class actions are common. D&O insurance is not federally mandated but is effectively universal because of the litigation risk. Premiums are the highest globally.
Australia’s regime is closer to the UK’s, with Section 180 of the Corporations Act, 2001 imposing the equivalent due-care standard.
Why India is converging toward strict-liability standards
Three drivers. SEBI’s enforcement intensity has stepped up in 2024-2026. Audit committee diligence expectations are rising. The Section 149(12) safe harbour has been narrowed by the SEBI orders walked through in the 2024-2025 case-walk above. India’s regime is no longer a soft-edged framework with a four-limb defence. It is a tighter framework where the four-limb test is contestable on functional grounds.
D&O premium and capacity comparison
US D&O capacity is the deepest globally. Indian capacity is meaningful but smaller; large-limit Indian policies often involve international reinsurers. Claim ratios in India are still below US levels but rising, with a noticeable jump in 2024-2025. The Tata AIG vs ICICI Lombard vs HDFC Ergo question (which Indian carrier offers the best wording) is policy-specific and depends on the negotiated language. A short comparison is outside the scope of this guide and warrants a dedicated post.
Board acceptance checklist: 15 questions every prospective ID must ask
This is the take-home section. The fifteen questions below are the practical due-diligence framework that senior independent directors run before accepting a new board seat. Each question is designed to be diagnostic. A weak answer to any of them is a signal. A weak answer to three or more is a reason to walk away.
Board governance review (5 questions)
| # | Question | Why it matters | What a “no” or weak answer signals |
|---|---|---|---|
| 1 | Can I review the last three years of board and audit committee minutes? | Tests whether the company runs a real governance process or a paper one | Refusal: governance opacity; redactions: structural issues |
| 2 | What is the audit committee charter and how often does it actually meet? | Verifies that the audit committee is functioning, not merely existing | Generic charter or fewer than four meetings per year: high-risk |
| 3 | What related-party transactions have been undertaken in the last three years, and what was the audit committee’s review process? | Tests one of the highest-risk areas under Section 188 of the Companies Act | Lack of clear documentation: structural exposure |
| 4 | What regulatory actions, SCNs, or investigations has the company faced in the last five years? | Tests for inherited exposure under D&O exclusions | Undisclosed actions or pending matters: prior-acts exclusion may bar coverage |
| 5 | When was the last independent director independence audit conducted? | Tests for functional-independence compliance | No audit: Maxheights-style misclassification risk |
D&O policy review (5 questions)
| # | Question | Why it matters | What a “no” or weak answer signals |
|---|---|---|---|
| 6 | What is the policy limit and how does it compare to the company’s market capitalisation and industry exposure? | Tests adequacy | A Rs 5 crore limit on a top-1000 listed company is structurally inadequate |
| 7 | What are the sub-limits, particularly for regulatory penalties, investigation costs, and DPDP/ESG/AI claims? | Tests granular adequacy | Low sub-limits expose the director despite a high headline limit |
| 8 | What are the major exclusions, and how are they worded (especially the fraud trigger)? | Tests for in-fact vs final-adjudication trigger | In-fact trigger: high-risk |
| 9 | Is there a clean severability clause? | Tests whether the director is protected from a co-director’s findings | Weak severability: co-director fraud can cancel coverage |
| 10 | Does the policy provide defence-cost advancement on a current basis? | Tests whether the director funds defence personally | No advancement: real-world unaffordability of defence |
Indemnification and run-off (5 questions)
| # | Question | Why it matters | What a “no” or weak answer signals |
|---|---|---|---|
| 11 | Is there a written indemnification deed in my favour? | Side B coverage relies on an underlying deed | No deed: Side B claim may be denied |
| 12 | What run-off cover is provided at exit, and who pays? | Determines post-resignation protection | Director funds run-off personally: significant cost |
| 13 | Am I IICA proficiency-test exempt or required to sit it? | Affects appointment validity and personal cost | If required, the company should reimburse |
| 14 | What is the sitting-fee structure and how is it indexed to risk? | Tests whether compensation matches exposure | Below-market fees with high exposure: economic mismatch |
| 15 | What is the compliance officer reporting line, and can I escalate concerns confidentially? | Tests the practical “voice” the director will have | If concerns must route through the MD: governance risk |
If the company answers question 1 with a refusal, the conversation typically ends there. If it answers questions 6 to 10 with vague language, the broker should be brought into the conversation to clarify. If questions 11 and 12 cannot be answered concretely (deed not yet drafted, run-off not budgeted), those should be conditions to acceptance, not optional add-ons.
A practical IICA proficiency-test note: the IICA proficiency exam is mandatory for most independent directors unless they qualify for an exemption (10+ years of CXO experience or specific qualifications). The 2026 syllabus and fees are tracked separately. The exemption is a one-time application, not an automatic outcome.
A pattern that holds up in inquiry after inquiry: the fifteen-question framework works best when reduced to a written exchange with the company secretary and the broker, before any indemnification deed is signed. The written record is itself a defence in any subsequent inquiry. It shows the director did the diligence the role required.
Board acceptance checklist: 15 questions every prospective ID must ask
Frequently asked questions
1. What is the liability of an independent director under Section 149(12) of the Companies Act, 2013?
An independent director is personally liable under Section 149(12) only for company acts that occurred with their knowledge through board processes, with their consent or connivance, or where they failed to act diligently. The four-limb test functions as a conditional safe harbour. Audit committee membership elevates the diligence standard, and SEBI’s 2024-2025 enforcement walk has narrowed the practical reach of the defence.
2. Is D&O insurance mandatory for independent directors in India in 2026?
D&O insurance is mandatory for the top 1,000 listed companies under Regulation 25(10) of the SEBI LODR Regulations, 2015 (as amended in 2021). For other listed and unlisted companies, the cover is not legally mandated but is the universal market expectation. Directors of regulated-sector unlisted companies should treat the cover as a baseline before accepting a board seat.
3. What does Side A coverage in a D&O policy actually pay for?
Side A pays the director directly when the company is unable (typically due to insolvency) or unwilling (due to a controlling-shareholder dispute) to indemnify. It is the protection that most directly targets the director’s personal balance sheet. Side A standalone policies, layered on the company’s main programme, are increasingly common for senior independent directors.
4. What is the difference between Side A, Side B, and Side C coverage?
Side A pays the director directly when the company cannot or will not indemnify. Side B reimburses the company when the company has paid the director under the indemnification deed. Side C provides entity-level cover, typically restricted in India to securities-claim cover (allegations of misstatement in offer documents or periodic disclosures). Side D, increasingly important, covers regulatory investigation costs at the pre-claim stage.
5. How much does D&O insurance cost in India in 2026?
A Rs 1 crore cover for an early-stage startup runs Rs 25,000 to Rs 80,000 annually. Rs 10 crore for a small-to-mid listed company runs Rs 1.5 lakh to Rs 4 lakh. Rs 100 crore plus for a large listed financial services or pharma company runs Rs 15 lakh to over Rs 1 crore. Broker reports indicate substantial year-on-year premium hikes in 2024-2026. Side A standalone adds Rs 50,000 to Rs 5 lakh on top.
6. What is the SEBI mandate for D&O insurance for top 1,000 listed companies?
Regulation 25(10) of the SEBI LODR Regulations, 2015, as amended in August 2021 (effective January 2022), requires the top 1,000 listed companies (by market capitalisation) to take out D&O insurance for all independent directors of such quantum and risk as the board may determine. The mandate previously covered only the top 500 listed companies before the 2021 amendment.
7. What if the company is bankrupt and cannot indemnify me?
When the company is in insolvency, Side A becomes the primary mechanism for paying defence costs and any covered settlements or judgments. Side B (which reimburses the company) is irrelevant because the company is not paying. Senior independent directors of high-risk companies often take Side A standalone policies to address this exact scenario, since the company’s main programme can be exhausted across multiple insureds.
8. Can an independent director be personally sued by SEBI?
Yes. SEBI has imposed personal monetary penalties on independent directors in multiple 2024-2025 orders, including the Brightcom Group matter (Rs 30 lakh penalty) and the Maxheights Infrastructure matter (Rs 9 lakh penalty). The legal threshold is the “significant role” test from the Chintalapati Srinivasa Raju ruling, narrowed in practice by the audit committee elevated standard.
9. Can independent directors be arrested in India?
Yes, but the threshold is high. Arrest typically requires a cognisable offence under the Companies Act 2013 (Section 447 fraud), the Prevention of Money Laundering Act, the SFIO regime, or other specific statutes. The MCA’s General Circular No. 05/2020 requires concrete evidence of personal complicity for prosecutions against independent directors. Arrests of independent directors have occurred but are uncommon outside major fraud investigations.
10. Are independent directors personally liable for company debts?
Generally no. The principle of separate corporate personality protects directors from company debts. Personal liability arises in specific situations: under Section 66 of the IBC for fraudulent or wrongful trading, under Section 138 of the NI Act for cheque dishonour where the director is in charge of business, under FEMA and PMLA for officer-attribution, and under tax laws where the company defaults on undisputed dues.
11. Does D&O insurance cover criminal proceedings?
Most D&O policies cover defence costs in criminal proceedings, subject to specific exclusions for fraud and intentional misconduct. The fraud exclusion typically operates on a “final adjudication” basis (so defence is funded through to final court finding) or an “in fact” basis (so defence is denied as soon as a fraud finding is made at any level). Fines and penalties for criminal convictions are typically excluded. Civil regulatory penalties are often covered subject to sub-limits.
12. Does the company pay the D&O premium, or does the director?
The company pays the premium under Section 197(13) of the Companies Act, 2013. The premium is generally tax-deductible to the company and is not treated as a perquisite to the director, provided the director is not finally found liable for the underlying conduct. If the director is finally found liable, the premium attributable to that director can be reclassified as remuneration. Side A standalone policies, where the director holds personal cover, are typically director-paid.
13. What disclosures must an independent director make on resignation?
Under the SEBI LODR Regulations, 2015 (as amended in 2021), the resigning director must disclose the actual reasons for resignation. The company must publish the disclosure on its website and submit it to the stock exchange within 7 days. “Personal reasons” boilerplate without specificity is no longer acceptable. The disclosure has been actively used by SEBI to open inquiries where directors cited financial-reporting concerns.
14. What is the cooling-off period after independent director resignation?
A 1-year cooling-off applies before a resigning independent director can take a non-independent role at the same listed entity. The Companies (Amendment) Bill 2026 proposes to extend this to holding, subsidiary, and associate companies. The cooling-off does not prevent the director from joining unrelated boards.
15. D&O insurance vs E&O (Errors and Omissions) insurance: what’s the difference?
D&O covers wrongful acts in the insured’s directorial or officer capacity. E&O (Errors and Omissions) covers professional services rendered by a firm to clients. A law firm carries E&O for advice given to clients. The same firm’s directors carry D&O for their directorial conduct. The two are distinct policies; some companies layer both. For independent directors, D&O is the primary cover. E&O typically does not apply.
16. Liability of independent directors vs executive directors in India
Section 149(12) does not apply to executive directors. Their liability is broader, covering all four limbs without the safe-harbour conditional structure. They face direct liability under Section 166 (fiduciary duties), under SEBI LODR (operational compliance), and under most officer-attribution statutes. Independent directors have the conditional protection of Section 149(12) but face the elevated diligence standard for audit committee membership.
17. D&O premium for Rs 1 crore cover vs Rs 10 crore cover vs Rs 100 crore cover
Rs 1 crore cover for a startup or small private company runs Rs 25,000 to Rs 80,000 annually. Rs 10 crore cover for a small-to-mid listed company runs Rs 1.5 lakh to Rs 4 lakh annually. Rs 100 crore cover for a large listed company in financial services, pharma, or infrastructure runs Rs 15 lakh to over Rs 1 crore annually. Premiums scale non-linearly because higher limits attract additional reinsurance and US-listing exposure premiums. Sector loading and claims history materially affect the ratio.
18. What does “wilful misconduct” mean in a D&O exclusion clause?
Wilful misconduct denotes intentional wrongful acts done with knowledge of their wrongfulness. Most D&O policies exclude wilful misconduct alongside fraud and dishonesty. The trigger language matters. A “final adjudication” trigger excludes coverage only after a final court finding. An “in fact” trigger excludes coverage as soon as the insurer or any court finds wilful misconduct on the facts. Negligence and ordinary errors of judgment fall outside the exclusion.
References
Case Law
- Aneeta Hada v. M/s Godfather Travels & Tours Pvt. Ltd., (2012) 5 SCC 661: Supreme Court 3-Judge Bench (27 April 2012)
- Chintalapati Srinivasa Raju v. Securities and Exchange Board of India, (2018) 7 SCC 443: Supreme Court Division Bench (14 May 2018)
- Iridium India Telecom Ltd. v. Motorola Incorporated, (2011) 1 SCC 74: AIR 2011 SC 20; Supreme Court Division Bench (20 October 2010)
- National Small Industries Corp. Ltd. v. Harmeet Singh Paintal, (2010) 3 SCC 330: Supreme Court Division Bench (15 February 2010)
- Pooja Ravinder Devidasani v. State of Maharashtra, (2014) 16 SCC 1: AIR 2015 SC 675; Supreme Court Division Bench (17 December 2014)
- SEBI v. Brightcom Group Ltd.: SEBI Adjudication Order (23 September 2024); SEBI Final Order (6 February 2025)
- SEBI v. Manpasand Beverages Limited, SEBI Order (April 2024)
- SEBI v. Maxheights Infrastructure Limited, SEBI Adjudication Order (June 2024)
- Standard Chartered Bank v. Directorate of Enforcement, (2005) 4 SCC 530: Supreme Court 5-Judge Constitution Bench (5 May 2005). Indian Kanoon hosts the 2006 same-matter follow-up ruling at /doc/1915525/.
- Sunil Bharti Mittal v. Central Bureau of Investigation, (2015) 4 SCC 609: AIR 2015 SC 923; Supreme Court 3-Judge Bench (9 January 2015)
- Sunita Palita v. M/s. Panchami Stone Quarry, (2022) 10 SCC 152: 2022 INSC 774; Supreme Court Division Bench (1 August 2022)
Statutes and Subordinate Legislation
- Indian Contract Act, 1872: sections cited 124, 125
- Negotiable Instruments Act, 1881: sections cited 138, 141
- Companies Act, 2013: sections cited 149, 149(6), 149(12), 166, 177, 188, 197, 197(13), 212, 447
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (last amended 22 January 2026): regulations cited 17, 18, 25, 25(10), 36
- Insolvency and Bankruptcy Code, 2016: sections cited 43, 45, 50, 66, 67, 69
- Insurance Ombudsman Rules, 2017: referenced in claim-dispute discussion (claim process section)
- National Financial Reporting Authority Rules, 2018: referenced in 9-statute exposure map (civil and statutory liability section)
- Companies (Amendment) Act, 2020: referenced in decriminalisation discussion (D&O introduction section)
- Digital Personal Data Protection Act, 2023: section cited 17
- Income-tax Act, 2025: premium deductibility framework (in force from 1 April 2026)
SEBI Orders and Informal Guidance
- SEBI v. Manpasand Beverages Limited, SEBI Order (April 2024)
- SEBI v. Maxheights Infrastructure Limited, SEBI Adjudication Order (June 2024)
- SEBI v. Brightcom Group Limited, Adjudication Order (23 September 2024)
- SEBI v. Brightcom Group Limited, Final Order (6 February 2025)
- SEBI Informal Guidance to InfoBeans Technologies Limited (May 2025)
MCA Circulars
- MCA General Circular No. 05/2020 dated 2 March 2020: Clarification on prosecutions filed or internal adjudication proceedings initiated against Independent Directors, non-promoters and non-KMP non-executive directors. (Official MCA URL: mca.gov.in/Ministry/pdf/Circular_03032020.pdf. Note: this URL is intermittently blocked from cloud-hosted networks; the circular text is also available through legal commentary and IBC Laws republication.)
IRDAI Regulatory Framework
- Insurance Regulatory and Development Authority of India: D&O insurance is regulated under the IRDAI’s general insurance product framework, with claim-dispute remedies under the Insurance Ombudsman Rules, 2017.
Secondary Commentary
- LiveLaw: case commentary on the 2024-2025 SEBI enforcement walk against independent directors.
- PRS India: legislative tracker for the Companies (Amendment) Bill 2026.
Legal Disclaimer
This article is for informational purposes only and does not constitute legal advice. For specific legal guidance, consult a qualified legal professional.
Become an Independent Director!
Join our 30 days live training program just for Rs. 100 →
Serato DJ Crack 2025Serato DJ PRO Crack
Allow notifications
